FDA Invites Patient Organizations to Take a Place at the Podium

By: Theresa M. Mullin, Ph.D. Sometimes, the most valuable thing we can do as regulators at FDA is simply to listen. I’m reminded of that each time we hold a public meeting as part of the Patient-Focused Drug Development (PFDD) … Continue reading →

Source: FDA Voice - January 23, 2016 Category: American Health Source Type: blogs